NCT04036240 is a NA clinical trial of Finger feeding in Low-Birth-Weight Infant, sponsored by Fakultas Kedokteran Universitas Indonesia.

Who is sponsoring NCT04036240?

NCT04036240 is sponsored by Fakultas Kedokteran Universitas Indonesia.

What drugs are being tested in NCT04036240?

Interventions in NCT04036240: Finger feeding.

What condition does NCT04036240 study?

NCT04036240 studies Low-Birth-Weight Infant, Breast Feeding.

Is NCT04036240 still recruiting?

NCT04036240 is currently status unknown. Last updated 27 December 2019.

Last reviewed 2019-12-27 · How we verify

NCT04036240

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Finger Feeding as a Method of HMF Supplementation After Discharge

Status unknown NA Last updated 27 December 2019

What this trial tests

NA trial testing Finger feeding in Low-Birth-Weight Infant in 78 participants. Status unknown.

Timeline

22 July 2019

Primary endpoint
30 December 2019

31 January 2020

Quick facts

Lead sponsor	Fakultas Kedokteran Universitas Indonesia
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	treatment
Enrollment	78
Start date	22 July 2019
Primary completion	30 December 2019
Estimated completion	31 January 2020
Sites	4 locations across Indonesia

Drugs / interventions tested

Finger feeding

Conditions studied

Low-Birth-Weight Infant — all drugs for Low-Birth-Weight Infant →
Breast Feeding — all drugs for Breast Feeding →

Sponsor

Fakultas Kedokteran Universitas Indonesia — full company profile →

Who can join

3 Days and older, any sex, with Low-Birth-Weight Infant or Breast Feeding. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Human Milk Fortifier (HMF) is designed to supply additional calories, protein, vitamins and minerals to infants less than 37 weeks gestation or those less than 1500 g at birth. Liquid and powder types of HMF are available in the commercial market. Usually, one packet of powdered HMF is mixed to 25-50 cc expressed breast milk. Fortification of human milk is technically difficult in fully breastfed infants and artificial teats such as bottle feedings are common used. A study reported lower breastfeeding rate in intervention group who used HMF in comparison with control. Finger feeding method is associated with a better breastfeeding rate in hospital use. A feasibility study in Vienna reports finger feeding method as a way to provide fortification at home was acceptable.We hypothesize that finger feeding is an easy way for HMF supplementation after discharge to increase successful breastfeeding and improve growth in preterm and or low birth weight infants.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Finger feeding

Trials testing the same drug.

NCT05928715 — Effect of Finger Feeding · NA · unknown

Other Fakultas Kedokteran Universitas Indonesia trials

Trials by the same sponsor.

NCT07308275 — Longitudinal Evaluation of Direct Neurotization Technique in Breast Reconstruction With Fully Autologous Components · NA · not yet recruiting
NCT07156786 — N-Acetylcysteine Roles in Preserving Renal Function Measured by Urinary KIM-1 (Kidney Injury Molecule-1) and Serum Creat · Phase 2, PHASE3 · not yet recruiting
NCT06521957 — Effectiveness of CBT in Improving Psycho-Neuro-Endocrine Factors in Women Following In Vitro Fertilization Program · NA · recruiting
NCT05451433 — The Effect of Saccharomyces Boulardii in Clinical Presentation and Quality of Life Patient With IBS · NA · unknown
NCT05215301 — Assessment of Multidimensional Voice Program (MDVP) Parameters in Workers · unknown

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04036240 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Fakultas Kedokteran Universitas Indonesia
Last refreshed: 27 December 2019

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04036240.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing